3,7,12-trihydroxycholestan-26-oic acid has been researched along with 3-methylheptadecanoic acid in 1 studies
| Studies (3,7,12-trihydroxycholestan-26-oic acid) | Trials (3,7,12-trihydroxycholestan-26-oic acid) | Recent Studies (post-2010) (3,7,12-trihydroxycholestan-26-oic acid) | Studies (3-methylheptadecanoic acid) | Trials (3-methylheptadecanoic acid) | Recent Studies (post-2010) (3-methylheptadecanoic acid) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 15 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casteels, M; Croes, K; Mannaerts, GP; van Veldhoven, PP | 1 |
1 other study(ies) available for 3,7,12-trihydroxycholestan-26-oic acid and 3-methylheptadecanoic acid
| Article | Year |
|---|---|
Evidence for the importance of iron in the alpha-oxidation of 3-methyl-substituted fatty acids in the intact cell.
Topics: Animals; Cells, Cultured; Cholestanols; Fatty Acids; Iron; Iron Chelating Agents; Liver; Male; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Rats; Rats, Wistar | 1995 |